Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Large neutral amino acid transporter 1 (LAT1), encoded by the SLC7A5 gene, is a sodium-independent, pH-independent transporter that forms a heterodimeric complex with the glycoprotein CD98 (SLC3A2). LAT1 is highly expressed at the blood-brain barrier (BBB) and in various cancers, where it mediates the uptake of essential large neutral amino acids (such as leucine, phenylalanine, and tyrosine) and thyroid hormones. In oncology, LAT1 is significantly upregulated to meet the high metabolic and nutritional demands of rapidly proliferating tumor cells, making it a key therapeutic target. Inhibiting LAT1, such as with the selective inhibitor nanvuranlat (JPH203), deprives cancer cells of essential amino acids, leading to starvation, suppression of the mTORC1 pathway, and apoptosis. Conversely, LAT1's high expression at the BBB is exploited for drug delivery, allowing amino acid-mimetic drugs (e.g., levodopa, gabapentin) and prodrugs to cross into the central nervous system. Additionally, LAT1 is the primary mediator for the uptake of boronophenylalanine (borofalan) in boron neutron capture therapy (BNCT).
Inhibition of amino acid transport (for inhibitors like nanvuranlat) or utilization as a transport substrate to cross biological barriers (for prodrugs and substrates like levodopa, gabapentin, and borofalan)
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large neutral amino acid transporter 1 (LAT1).